If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMI.L Regulatory News (AMI)

  • There is currently no data for AMI

Marampa Update

25 Nov 2009 07:52

RNS Number : 0455D
African Minerals Ltd
25 November 2009
Β 

ο»Ώ

For immediate release

25 November 2009

African Minerals Limited

Β ("African Minerals", "AML" or "the Company")

Amendment to Marampa Agreements with Cape Lambert Iron Ore Limited

Highlights:

African Minerals amends agreement with Cape Lambert Iron Ore Limited ("CLIO") re Marampa project

Under the agreement, AML disposes of up to 100% interest in Marampa Iron Ore Limited in return for up to 19.9% of CLIO's issued share capital

Enables AML to focus fully its human and financial resources on its flagship 5.1bn tonne JORC compliant resource at Tonkolili and its associated infrastructure projects

Enables African Minerals to benefit further from additional exposure to CLIO's diverse portfolio of high quality resource assets and consolidates the relationship with CLIO

Allows AML to maintain and benefit from an indirect exposure to Marampa without requiring it to fund the construction and development of the Marampa project

African Minerals Limited (AIM:AMI), the mineral exploration and development company with significant iron ore and base metal interests in Sierra Leone, West Africa, announces that it has amended its agreements with Cape Lambert Iron Ore Limited ("CLIO") (ASX:CFE) in respect of the Marampa iron ore project, previously announced on 1 October 2008 (the "First Marampa Agreement") and 22 January 2009 (the "Second Marampa Agreement").

Under the terms of the amendment agreement ("Amendment Agreement"), AML has agreed to transfer to CLIO a furtherΒ 28% of the ordinary shares in Marampa Iron Ore Limited ("MIO"), which holds the Marampa exploration licence approximately 150kms northeast of Freetown, in return for 24,569,934 ordinary shares in CLIO (the "Initial Transfer"). This increases CLIO's stake in MIO to 63% and AML's stake in CLIO to 15.2%.Β 

In addition, under the terms of the Amendment Agreement, AML and CLIO have amended the terms of CLIO's existing option to acquire up to 100% of Marampa. Under the revised option terms, AML has granted CLIO the right to acquire the remaining 37% of MIO's ordinary shares in consideration for issuing to AML 32,592,789 ordinary CLIO shares (the "Second Transfer"). CLIO has, at the same time, elected to exercise that option. The Second Transfer is subject to the approval of CLIO shareholders at a General Meeting which must be convened by CLIO within 45 days from 25 November 2009. If approved, the issue of shares will increase AML's stake in CLIO from 15.2% to 19.9% and CLIO's stake in Marampa to 100%.Β 

At CLIO's closing share price yesterday of A$0.57 (US$0.53) the value of AML's stake in CLIO after the Initial Transfer is US$44.8m. Upon the Second Transfer, AML's stake in CLIO at the same closing price of A$0.57 (US$0.53) would be valued at US$62.0m.

Background to the First and Second Marampa Agreements

The First Marampa Agreement gave CLIO a 30% interest in Marampa for US$25m (of which only $5m needed to be committed at the time of signing) and 44m CLIO shares with a then market value of $13.2m. Under the First Marampa Agreement AML also granted CLIO an option to acquire all the outstanding shares in MIO for US$200M less the aggregate of US$25M and US$13.2M.Β 

By the Second Marampa Agreement CLIO increased its shareholding in Marampa from 30% to 35% in return for a further 17m CLIO ordinary shares with a then value of US$3.4m. CLIO retained the option to acquire the 65% balance of MIO's shares for US$200M less the aggregate of US$25M, US$13.2m and US$3.4m.Β 

Under both the First and Second Marampa Agreements CLIO's option was exercisable entirely at its discretion. In the event that CLIO chose not to exercise the option, the First and Second Marampa Agreements provided for a pro-rata reduction in CLIO's shareholding in MIO by reference to the consideration paid to date and for AML to retain its shareholding in CLIO.

Benefits of the transaction to AML

The Amendment Agreement, assuming the Second Transfer occurs, holds a number of key benefits to African Minerals:

It allows AML to focus its human and financial resources fully on the development of the much larger, 5.1bn tonne resource at Tonkolili and its related infrastructure projects

It allows AML to maintain and benefit from an indirect exposure to Marampa without requiring it to fund the construction and development of the Marampa project

It reduces AML's illiquid, direct interest in Marampa and increases the liquid, indirect interest in the project via CLIO's listed equity.

The increase in AML's shareholding in CLIO to 19.9% increases AML's exposure to the diverse portfolio of high quality resource assets held by CLIO.

It confirms the development of the project will be fullyΒ controlledΒ by a highly respected CLIO team who have been on site since October 2008.

As at 31 August 2009, MIO had net assets of US$24.7 million and there was a negligible loss for the year to date associated with the project. AML currently intends to retain the shares in CLIO.

By virtue of its status, before this transaction, as a 35% shareholder of an African Minerals subsidiary, CLIO is deemed to be a related party for the purposes of AIM Rule 13. In accordance with the AIM Rules, the directors consider, having consulted with the Company's nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.Β 

Frank Timis, Executive Chairman of AML commented:

"We are extremely pleased with the terms of the amended agreement. Not only is this a major step forward in consolidating the relationship between CLIO and AML, but it also provides AML with the necessary operational and financial flexibility to intensify our focus on our core project at Tonkolili. CLIO has a strong management team with a proven iron oreΒ industry track record and I am confident in CLIO's ability to realise the full potential of Marampa, demonstrating the attraction ofΒ Sierra LeoneΒ to mining companies.Β 

With the increased shareholding in CLIO, AML is well-positioned to benefit from CLIO's strong portfolio of assets whilst remaining fully focused on fast tracking the development of our world-class iron ore project at Tonkolili and the related infrastructure projects."

Β Enquiries:

Β 

African Minerals Limited

Tel: +44Β (0)Β 1481 726833

FrankΒ Timis

Alan Watling

Β 

Β 

Β 

Canaccord Adams Limited

Tel: +44Β (0)Β 20Β 7050Β 6500

Mike Jones

Robert Finlay

Β 

Β 

Β 

Mirabaud Securities Limited

Tel: +44Β (0)Β 20Β 7878Β 3360

Rory Scott

Pav Sanghara

Β 

Β 

Β 

Pelham Public Relations Limited

Tel: +44Β (0)Β 20Β 7337 1500

Charles Vivian

Klara Kaczmarek

Β 

James Macfarlane

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGRIIFSDLALEFIA
Date   Source Headline
16th Dec 201310:15 amRNSAdditional Listing on Exercise of Share Options
5th Nov 20137:00 amRNSQ3 2013 Production Report
26th Sep 20134:17 pmRNSRESOLUTIONS PASSED AT 2013 AGM
26th Sep 20137:00 amRNSProposed Strategic Investment
11th Sep 20137:00 amRNSrelated party transactions with Shandong
11th Sep 20137:00 amRNSInterim Results 2013
14th Aug 20137:00 amRNSDirectorate Change CEO
14th Aug 20137:00 amRNSDirectorate Change CFO
29th Jul 20137:00 amRNSQ2 2013 Production Report
22nd Jul 20134:33 pmRNSAdditional Listing on Exercise of Share Options
22nd Jul 20137:00 amRNSAppointment of Vice Chairman
28th Jun 20137:00 amRNSPosting of Annual Report and Accounts
26th Jun 201310:01 amRNSDirector/PDMR Shareholding
18th Jun 20137:00 amRNSAchievement of 20Mtpa export rate
22nd May 20138:58 amRNSHolding(s) in Company
14th May 201312:20 pmRNSHolding(s) in Company
14th May 201312:19 pmRNSHolding(s) in Company
14th May 201312:18 pmRNSHolding(s) in Company
19th Apr 20131:48 pmRNSAdditional Listing on Exercise of Share Options
18th Apr 201311:57 amRNSHolding(s) in Company
10th Apr 20137:00 amRNSFull Year Results
4th Mar 20137:00 amRNSAdditional Listing on Exercise of Share Options
5th Feb 20137:00 amRNSConfirmation of new financing arrangements
4th Feb 20137:00 amRNSChange of Nominated Adviser and Broker
14th Jan 20137:00 amRNSAppointment of Chief Operating Officer
4th Jan 20133:08 pmRNSDirector Share Dealing
27th Dec 20125:12 pmRNSDirector share dealing
18th Dec 20129:05 amRNSRaising of Limit of Ownership by CRM
18th Dec 20129:02 amRNSExpansion Update
17th Dec 20124:20 pmRNSOperational and Funding Update
13th Dec 20127:00 amRNSHolding(s) in Company
4th Dec 20127:00 amRNSHolding(s) in Company
23rd Nov 201212:00 pmRNSEstablishment of Finance Credit Facility
21st Nov 20125:44 pmRNSOperational and Financing Update Conference Call
21st Nov 201212:26 pmRNSOperational and Financing Update
1st Nov 20124:45 pmRNSRelated Party Transactions
11th Sep 20127:00 amRNSInterim Results
3rd Sep 20127:00 amRNSAppointment of Senior Personnel
24th Aug 20127:00 amRNSProject Update
2nd Aug 20123:34 pmRNSResult of AGM
17th Jul 20123:16 pmRNSAdditional Listing on Exercise of Share Options
13th Jul 20124:46 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Jul 20125:44 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Jul 201212:04 pmRNSGrant of Share Options
5th Jul 20124:45 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Jul 20127:00 amRNSChange of directors
4th Jul 20127:00 amRNSAppointment of Chief Executive Officer
28th Jun 20124:16 pmRNS2011 Annual Report & Accounts and Notice of AGM
1st Jun 20126:36 pmRNSDirector/PDMR Shareholding
16th May 20125:33 pmRNSDirector share dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.